Okla. Stat. tit. 63, § 63-5031
This is the official text of Okla. Stat. tit. 63, § 63-5031, part of Oklahoma’s Stat. tit. 63, — part of the compiled statutory law of Oklahoma, published by the state as "Stat. tit. 63,." Browse the sections below, each linked to its official government source.
Not legal advice. This page reproduces the official text of a government statute for reference only. Laws change, and how a statute applies depends on your specific facts. For advice about your situation, consult a licensed attorney in your state.
Nonopioid drugs not to be disadvantaged or discouraged
Official statutory text
A. As used in this section, “contracted entity” has the same
meaning as provided by Section 4002.2 of Title 56 of the Oklahoma
Statutes.
B. In establishing and maintaining the formulary for the state
Medicaid program, the Oklahoma Health Care Authority shall ensure
that no nonopioid drug approved by the United States Food and Drug
Administration (FDA) for the treatment or management of pain shall
be disadvantaged or discouraged by either the Authority or a
contracted entity with respect to coverage on the formulary relative
to any opioid or narcotic drug for the treatment or management of
pain.
C. When a contracted provider prescribes an FDA-approved
nonopioid drug for the treatment or management of pain, the
Authority or a contracted entity shall not deny coverage of the
nonopioid drug in favor of an opioid drug.
D. This section does not preclude opioid drugs from being
preferred over other opioid drugs or nonopioid drugs from being
preferred over other nonopioid drugs.
meaning as provided by Section 4002.2 of Title 56 of the Oklahoma
Statutes.
B. In establishing and maintaining the formulary for the state
Medicaid program, the Oklahoma Health Care Authority shall ensure
that no nonopioid drug approved by the United States Food and Drug
Administration (FDA) for the treatment or management of pain shall
be disadvantaged or discouraged by either the Authority or a
contracted entity with respect to coverage on the formulary relative
to any opioid or narcotic drug for the treatment or management of
pain.
C. When a contracted provider prescribes an FDA-approved
nonopioid drug for the treatment or management of pain, the
Authority or a contracted entity shall not deny coverage of the
nonopioid drug in favor of an opioid drug.
D. This section does not preclude opioid drugs from being
preferred over other opioid drugs or nonopioid drugs from being
preferred over other nonopioid drugs.
Status: in_force · Read it on the official government site
Need a lawyer in Oklahoma?
Find a Oklahoma lawyer
About this page: Statute text is reproduced from official government publishers via the
Open US Law dataset
(Vaquill AI, snapshot v2026.08, CC BY 4.0). Primary legislative text like this is public domain under the government-edicts doctrine
(Georgia v. Public.Resource.Org, 2020). We link every section back to its official source so you can verify it independently.